Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Eccleston

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
JMIR Formative Research|July 31, 2024
Impact of a Health Coach-Led, Text-Based Digital Behavior Change Intervention on Weight Loss and Psychological Well-Being in Patients Receiving a Procedureless Intragastric Balloon Program: Prospective Single-Arm StudyPaul M Sacher, Emily Fulton, Victoria Rogers, et al.
American Heart Journal|December 17, 2008
Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) TrialGerald Yong, Jamie Rankin, Louise Ferguson, et al.
Coronary Artery Disease|April 21, 2016
Early versus delayed percutaneous coronary intervention in patients with non-ST elevation acute coronary syndromesMatias B Yudi, Andrew E Ajani, Nick Andrianopoulos, et al.
Heart, Lung & Circulation|July 26, 2025
A Prospective, Multicentre Randomised Controlled Study of Angiographic and Clinical Outcomes in Total Arterial Coronary Bypass Grafting: The TA Trial ProtocolAlistair Royse, Justin Ren, Andrea Bowyer, et al.
The American Journal of Cardiology|March 5, 2021
Comparison of Long-Term Outcomes After Percutaneous Coronary Intervention in Patients With Insulin-Treated Versus Non-Insulin Treated Diabetes MellitusSinjini Biswas, Diem Dinh, Nick Andrianopoulos, et al.
The American Journal of Cardiology|May 13, 2017
Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry)Julian Yeoh, Matias B Yudi, Nick Andrianopoulos, et al.
The Medical Journal of Australia|October 4, 2006
Use of drug-eluting stents in Victorian public hospitalsBryan P Yan, Andrew E Ajani, Stephen J Duffy, et al.
American Heart Journal|April 21, 2009
The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stentsMichelle J Butler, David Eccleston, David J Clark, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 6, 2005
What is the best contemporary treatment for in-stent restenosis?Peter Barlis, Mark C G Horrigan, Robert K Chan, et al.
Trials|September 2, 2025
Preoperative focused echocardiography on patients with fractured neck of femur. ECHONOF-III trial: study protocol for a multicenter randomized controlled trialXimena Cid-Serra, Alistair Royse, Andrea Bowyer, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
JMIR Formative Research|July 31, 2024
Impact of a Health Coach-Led, Text-Based Digital Behavior Change Intervention on Weight Loss and Psychological Well-Being in Patients Receiving a Procedureless Intragastric Balloon Program: Prospective Single-Arm StudyPaul M Sacher, Emily Fulton, Victoria Rogers, et al.
American Heart Journal|December 17, 2008
Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) TrialGerald Yong, Jamie Rankin, Louise Ferguson, et al.
Coronary Artery Disease|April 21, 2016
Early versus delayed percutaneous coronary intervention in patients with non-ST elevation acute coronary syndromesMatias B Yudi, Andrew E Ajani, Nick Andrianopoulos, et al.
Heart, Lung & Circulation|July 26, 2025
A Prospective, Multicentre Randomised Controlled Study of Angiographic and Clinical Outcomes in Total Arterial Coronary Bypass Grafting: The TA Trial ProtocolAlistair Royse, Justin Ren, Andrea Bowyer, et al.
The American Journal of Cardiology|March 5, 2021
Comparison of Long-Term Outcomes After Percutaneous Coronary Intervention in Patients With Insulin-Treated Versus Non-Insulin Treated Diabetes MellitusSinjini Biswas, Diem Dinh, Nick Andrianopoulos, et al.
The American Journal of Cardiology|May 13, 2017
Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry)Julian Yeoh, Matias B Yudi, Nick Andrianopoulos, et al.
The Medical Journal of Australia|October 4, 2006
Use of drug-eluting stents in Victorian public hospitalsBryan P Yan, Andrew E Ajani, Stephen J Duffy, et al.
American Heart Journal|April 21, 2009
The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stentsMichelle J Butler, David Eccleston, David J Clark, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 6, 2005
What is the best contemporary treatment for in-stent restenosis?Peter Barlis, Mark C G Horrigan, Robert K Chan, et al.
Trials|September 2, 2025
Preoperative focused echocardiography on patients with fractured neck of femur. ECHONOF-III trial: study protocol for a multicenter randomized controlled trialXimena Cid-Serra, Alistair Royse, Andrea Bowyer, et al.
Pageof 4